These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 3266023

  • 1. T-cell response to purified protein derivative after removal of Langerhans' cells from epidermal cell suspensions containing keratinocytes expressing class II transplantation antigens.
    Tjernlund U, Scheynius A, Johansson C, Hagforsen E, Nilsson H.
    Scand J Immunol; 1988 Dec; 28(6):667-73. PubMed ID: 3266023
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L, Rönnelid J, Sanjeevi CB, Lampa J, Klareskog L.
    Arthritis Res; 2000 Dec; 2(1):75-84. PubMed ID: 11219392
    [Abstract] [Full Text] [Related]

  • 4. Expression of MHC class II antigens (HLA DR, DP and DQ) by keratinocytes in oral lichen planus.
    Farthing PM, Cruchley AT.
    J Oral Pathol Med; 1989 May; 18(5):305-9. PubMed ID: 2475620
    [Abstract] [Full Text] [Related]

  • 5. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation.
    Meunier L, Bohjanen K, Voorhees JJ, Cooper KD.
    J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614
    [Abstract] [Full Text] [Related]

  • 6. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions.
    Sontheimer RD.
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806
    [Abstract] [Full Text] [Related]

  • 7. Amplified T cell response to PPD by epidermal cell suspensions containing HLA-DR-expressing keratinocytes.
    Tjernlund U, Scheynius A.
    Acta Derm Venereol Suppl (Stockh); 1988 Jul; 135():57. PubMed ID: 3259359
    [No Abstract] [Full Text] [Related]

  • 8. Effects of purified protein derivative (PPD)-activated syngeneic epidermal cells on a PPD-specific rat T-helper cell line.
    Scheynius A, Larsson P, Skoglund C, Holmdahl R, Klareskog L.
    Scand J Immunol; 1989 Jun; 29(6):671-7. PubMed ID: 2525808
    [Abstract] [Full Text] [Related]

  • 9. Differential expression of major histocompatibility complex class II antigens on human keratinocytes.
    Niedecken H, Lutz G, Bauer R, Kreysel HW.
    J Am Acad Dermatol; 1988 Dec; 19(6):1030-7. PubMed ID: 2462575
    [Abstract] [Full Text] [Related]

  • 10. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
    Hansen ER, Bang B, Larsen JK, Vejlsgaard GL, Baadsgaard O.
    Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
    [Abstract] [Full Text] [Related]

  • 11. Functional analysis of HLA-DR-expressing keratinocytes from tuberculin reactive skin.
    Morikawa M, Yasue T, Ohashi M.
    J Dermatol; 1991 Apr; 18(4):187-95. PubMed ID: 1918592
    [Abstract] [Full Text] [Related]

  • 12. Class II transplantation antigens in the late human skin tuberculin reaction.
    Scheynius A, Tjernlund U.
    Scand J Immunol; 1985 Aug; 22(2):227-33. PubMed ID: 2412281
    [Abstract] [Full Text] [Related]

  • 13. In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction.
    Scheynius A, Klareskog L, Forsum U.
    Clin Exp Immunol; 1982 Aug; 49(2):325-30. PubMed ID: 6751638
    [Abstract] [Full Text] [Related]

  • 14. Studies on human epidermal langerhans cells. IV. HLA-D restriction of langerhans cell-dependent antigen activation of T lymphocytes.
    Braathen LR, Thorsby E.
    Scand J Immunol; 1982 Jan; 15(1):55-61. PubMed ID: 6176017
    [Abstract] [Full Text] [Related]

  • 15. The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a- antigen-presenting cells.
    Prens EP, Benne K, van Joost T, Benner R.
    J Invest Dermatol; 1991 Jun; 96(6):880-7. PubMed ID: 1710638
    [Abstract] [Full Text] [Related]

  • 16. Products of class II major histocompatibility complex gene subregions are differentially expressed on keratinocytes in cutaneous diseases.
    Barker JN, Ophir J, MacDonald DM.
    J Am Acad Dermatol; 1988 Oct; 19(4):667-72. PubMed ID: 2460509
    [Abstract] [Full Text] [Related]

  • 17. Human keratinocytes express HLA-DR antigens in the tuberculin reaction.
    Scheynius A, Tjernlund U.
    Scand J Immunol; 1984 Feb; 19(2):141-7. PubMed ID: 6367023
    [Abstract] [Full Text] [Related]

  • 18. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
    Ashworth J, Kahan MC, Breathnach SM.
    Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
    [Abstract] [Full Text] [Related]

  • 19. Loss of allogeneic T-cell activating ability and Langerhans cell markers in human epidermal cell cultures.
    Demidem A, Faure M, Dezutter-Dambuyant C, Thivolet J.
    Clin Immunol Immunopathol; 1986 Mar; 38(3):319-26. PubMed ID: 2935342
    [Abstract] [Full Text] [Related]

  • 20. Human gingival Langerhans cells stimulate allogeneic lymphocytes: requirement for MHC class II antigens.
    Walsh LJ, Seymour GJ, Powell RN.
    J Periodontol; 1990 Jun; 61(6):328-33. PubMed ID: 2366140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.